Allison Dorval - 29 Nov 2022 Form 4 Insider Report for Verve Therapeutics, Inc. (VERV)

Role
Chief Financial Officer
Signature
/s/ Andrew Ashe, as Attorney-in-Fact for Allison Dorval
Issuer symbol
VERV
Transactions as of
29 Nov 2022
Transactions value $
-$12,243
Form type
4
Filing time
01 Dec 2022, 16:00:17 UTC
Previous filing
22 Jun 2022
Next filing
16 Feb 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VERV Common Stock Options Exercise +1,875 +217% 2,740 29 Nov 2022 Direct F1, F2
transaction VERV Common Stock Sale -$12,243 -554 -20% $22.1 2,186 29 Nov 2022 Direct F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VERV Restricted Stock Units Options Exercise $0 -1,875 -25% $0 5,625 29 Nov 2022 Common Stock 1,875 Direct F1, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Restricted stock units ("RSUs") convert into common stock on a one-for-one basis. This transaction represents the settlement of RSUs in shares of common stock on their scheduled vesting date.
F2 Includes 865 shares of the Company's common stock acquired under the Verve Therapeutics, Inc. Amended and Restated 2021 Employee Stock Purchase Plan.
F3 Shares sold in sell-to-cover transaction in order to satisfy withholding taxes to be paid upon the vesting of RSUs on November 29, 2022. This sale does not represent a discretionary trade by the reporting person.
F4 On November 29, 2021, the reporting person was granted 7,500 RSUs pursuant to the Verve Therapeutics, Inc. 2021 Stock Incentive Plan. Each RSU represents a contingent right to receive one share of the Company's common stock upon vesting, with 25% of the RSU vesting on November 29, 2022 and the remainder vesting in equal annual installments until November 29, 2025.